Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 377INDUSTRY 117NIH 20OTHER_GOV 14NETWORK 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

NET 3Endocrine 3Sarcoma 1Myeloid 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Neuroendocrine Tumors 3Neoplasms 2Vipoma 1Somatostatinoma 1Pheochromocytoma 1Nephroma, Mesoblastic 1Myeloproliferative Disorders 1Melanoma 1Lymphoproliferative Disorders 1Insulinoma 1Glucagonoma 1Gastro-entero Pancreatic Neuroendocrine Tumors 1Gastrinoma 1Ganglioneuroma 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Islet Cell 1Carcinoma in Situ 1Adenoma, Islet Cell 1

Interventions

motesanib diphosphate 1batifiban 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Neuroendocrine Tumors × NET × Clear all
NCT02402244 2026-05-05

Project: Every Child for Younger Patients With Cancer

Children's Oncology Group

Recruiting
75,000 enrolled
CNSDermatologicEndocrineLymphoidMyeloidNETSarcoma

Carcinoma in Situ, Ganglioneuroma, Lymphoproliferative Disorders, Melanoma, Myeloproliferative Disorders, Neoplasms, Pheochromocytoma, Central Nervous System Neoplasms, Nephroma, Mesoblastic, Desmoid Tumors, Neuroendocrine Tumors

NCT06345079 2025-08-14

STOPNET

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting
78 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00427349 2023-07-05

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
EndocrineNET

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡